October 9, 2013

The Food and Drug Administration today approved Adempas, also known as riociguat, to treat adults with two forms of pulmonary hypertension, which is caused by abnormally high blood pressure in the arteries of the lungs.

July 10, 2013

A new study by researchers at the University of Washington provides further evidence that most of the health problems affecting the country are linked to lifestyle choices.

July 10, 2013

Pharmacists remotely monitoring patients helped them achieve better blood-pressure control than physicians in usual care, according to a new study.

June 3, 2013

People with Type 2 diabetes or high blood pressure should be evaluated for sleep apnea, a medical group said Monday.

May 22, 2013

The Food and Drug Administration has approved a generic heart disease drug made by Sandoz, the company said.

March 21, 2013

In collaboration with Walgreens, the University of Nebraska Medical Center unveiled a new treatment model to help positively impact clinical outcomes for hypertension and Type 2 diabetes patients through a program made possible by a National Association of Chain Drug Stores Foundation grant.

March 15, 2013

PharmaSmart International’s comprehensive blood pressure program has recently been validated in two new, independent scientific studies, the company announced today. The company also announced a partnership with Rx-30 Pharmacy System that offers an automated clinical integration of validated PharmaSmart biometrics within the patient record.

February 15, 2013

A new study indicates that the United States could prevent up to half a million deaths during the next 10 years by reducing salt intake, according to published reports.

February 14, 2013

The Food and Drug Administration has accepted the resubmission of a regulatory approval application from United Therapeutics for a drug to treat pulmonary arterial hypertension, the drug maker said.

February 11, 2013

Bartell Drugs has introduced PharmaSmart blood pressure testing kiosks at all 58 of its stores, the regional retail pharmacy chain said Monday.

February 1, 2013

Patients who take a drug for losing weight may experience improvement in multiple cardiovascular disease risk factors, according to a new study.

December 7, 2012

The Food and Drug Administration has approved a generic hypertension drug made by Mylan, the company said.

November 19, 2012

Dr. Reddy's Labs has launched a generic drug for treating pulmonary arterial hypertension, the company said.

November 13, 2012

The Food and Drug Administration has approved a generic drug made by Mylan for treating pulmonary arterial hypertension, the drug maker said Tuesday.

November 12, 2012

The Food and Drug Administration has approved a generic drug for pulmonary arterial hypertension made by Watson Pharmaceuticals, the drug maker said Monday.

November 8, 2012

Members of a prescription-drug program offered by Humana to Medicare beneficiaries will soon be able to obtain hypertension drugs from Walmart for a penny.

October 23, 2012

The Food and Drug Administration is expected to decide at the end of this week whether to approve a new oral drug for pulmonary arterial hypertension made by United Therapeutics.

October 18, 2012

A company that makes health kiosks has joined a campaign to promote blood pressure management among patients with hypertension.

September 28, 2012

Generic drug maker Mylan has received regulatory approval for a drug used to treat high blood pressure, also known as hypertension, the company said Friday.

September 21, 2012

The Food and Drug Administration has approved a blood pressure medication made by Mylan.

September 11, 2012

Generic drug maker Dr. Reddy's Labs has launched a generic drug for treating high blood pressure, the company said.

September 10, 2012

Some of the most commonly cited health problems affecting the elderly are hypertension, stroke and osteoporosis, but a new study highlights what researchers call an even bigger problem.

September 7, 2012

A Takeda drug designed to treat hypertension was statistically superior to another drug combination in reducing systolic blood pressure among patients in a 10-week, late-stage clinical trial.

September 5, 2012

The National Community Pharmacists Association on Wednesday announced that it is participating in the "Team Up. Pressure Down." program to help hypertensive patients more effectively manage and control their high blood pressure — and ultimately prevent 1 million heart attacks and strokes by 2017.